1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grants2025 Translational Research Grants is sponsored by New York Fund for Innovation in Research and Scientific Talent (NYFIRST). Provides grants to medical schools to attract and retain world-class translational research scientists in New York State, aiming to cultivate biotech startups and foster economic growth.
Get alerted about grants like this
Save a search for “New York Fund for Innovation in Research and Scientific Talent (NYFIRST)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
New York Fund for Innovation in Research and Scientific Talent -... Opened/Updated This Week 0 $0 Opened/Updated This Week 0 $0 Opened/Updated This Week 0 $0 New York Fund for Innovation in Research and Scientific Talent - Nyfirst The NYFIRST medical school grant program aims to support the recruitment or retention of exceptional life science researchers at New York State medical schools. The program offers a maximum grant of $1.
0 million, with a requirement for grantees to provide $2 in matching funds for every $1 of NYFIRST program assistance. Eligible expenses include laboratory establishment or upgrades, purchase of capital equipment and specialized supplies, and working capital for professional staff costs.
Eligible applicants are limited to medical schools in New York State, and the recruited or retained Principal Investigator must have a history of translational research and be pursuing innovative solutions for unmet clinical needs with a clear path to commercialization.
Additionally, the talent must demonstrate a history of entrepreneurship, be tenured or on a tenure track, hire from outside New York State or retain full-time scientists or doctoral students/post-doctoral fellows, and have potential for significant life sciences economic development benefits in New York State.
For detailed eligibility requirements, funding criteria, and application guidelines, potential applicants should refer to the Life Sciences Initiative Program Guidelines for the New York Fund for Innovation in Research and Scientific Talent (NYFIRST) Program. Private institutions of higher education - Only medical schools in New York State are eligible to apply for NYFIRST grants.
- The Principal Investigator must have a history of translational research and be pursuing research on an innovative solution for an unmet clinical need with a clear path to commercialization. - The Principal Investigator must demonstrate a history of entrepreneurship, have sufficient funding to support the research project for at least three years, and be tenured or on a tenure track.
- The Principal Investigator must hire from outside of New York State or retain at least two full-time scientists or doctoral students/post-doctoral fellows (or four part-time). - The research must have the potential to result in significant life sciences economic development benefits in New York State. - There are no restrictions with regard to the therapeutic area of research being pursued.
Opportunity Zone Benefits
According to the current listing, eligibility includes: Medical schools in New York State. Confirm the full requirements in the official notice before applying.
2025 Translational Research Grants is funded by New York Fund for Innovation in Research and Scientific Talent (NYFIRST). Verify program details on the funder's official page before applying.
This opportunity targets applicants in New York. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
DoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read articleNSF restarted its SBIR/STTR programs on May 31, 2026 after a multi-month hiatus, with a $250 million FY26 allocation, a Project Pitch portal reopen on June 2, and a first full-proposal deadline of July 27, 2026. The big structural changes: a new Strategic Breakthrough tier that extends invited Phase II companies up to $30 million, and a $40 million pilot for next-generation scientific instrumentation. Phase I tops out at $305K, Phase II at $1.25M, with November 4 and March 4, 2027 windows behind the July 27 first deadline. For deep-tech startups that watched the NIH SBIR omnibus go dark and DARPA pull back on conventional Phase II slots, this is the most consequential reopening of the year — and the Strategic Breakthrough tier is the first time NSF has competed directly with venture capital at growth-stage check sizes.
Read articleNIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read article